Associate Sarah Whitmore has authored "The Shifting Policy Perspective: Transparency," an article for FDLI's magazine Update. In the article, Sarah discusses Health Canada's move toward transparency and in particular with respect to Bill C-17, otherwise known as Vanessa's Law, a law intended to give Health Canada more power to safeguard Canadians from unsafe medications. Sarah also expands on the impact of Vanessa's Law on the pharmaceutical regulatory landscape.
To read the PDF of the article, click here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.